معرفی
Camron D. Bryant is a Professor in Pharmaceutical Sciences at Northeastern University's Bouvé College of Health Sciences. His research focuses on mapping genetic and neurobiological mechanisms underlying addiction, eating disorders, and pain through rodent forward genetic crosses, multi-omics, and gene editing. Key projects include validating Zhx2's role in opioid metabolism, developing near-isogenic substrains for genetic analysis, and applying machine learning to 'Big Behavior' datasets for opioid withdrawal studies. Dr. Bryant holds NIH BRLE study section membership (2021-2025) and is a past President of the International Behavioural and Neural Genetics Society (IBANGS).
Education
- PhD in Neuroscience, UCLA
- Postdoc in Rodent Quantitative Genetics, University of Chicago
- BSc in Psychology, University of Illinois at Urbana-Champaign
Research Interests
Dr. Bryant's lab investigates the genetic basis of addiction model traits (opioids, psychostimulants), binge eating, and pain. Current projects include:
- Zhx2 validation in oxycodone metabolism and addiction
- Machine learning analysis of opioid withdrawal behavior
- Rat substrain comparisons for cocaine addiction genetics
Awards
- Member, American College of Neuropsychopharmacology (2021)
- Early Career Scientist Award, International Behavioral and Neural Genetics Society (2014)
Advising & Grants
Dr. Bryant has supervised multiple postdocs and graduate students through NIH-funded projects. His lab employs 'Reduced Complexity Cross' strategies to accelerate gene discovery for complex traits. He also provides grant-writing training for NIH/NIDA initiatives.
Lab Activities
Current lab efforts focus on:
- Neonatal Opioid Withdrawal Syndrome (NOWS) hyperirritability studies
- Zhx2's role in opioid metabolism validation
- Rat substrain cocaine addiction genetics
